<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>SE-0-SE-6-15166A0101-AFR-12250</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)</narrative>
   <narrative xml:lang="SV">Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="SV">African Population Health and Research Center (APHRC) har hos Sida ans&#xF6;kt om 22,9 miljoner SEK f&#xF6;r att administrera finansiering av och tillhandah&#xE5;lla kapacitetsst&#xE4;rkande och n&#xE4;tverksbildande aktiviteter f&#xF6;r afrikanska forskare som beviljats anslag fr&#xE5;n Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) under perioden 2021-06-01 till 2024-12-31. Av ovann&#xE4;mnda beloppet kommer 14,6 miljoner SEK att vidarebefordras till afrikanska forskare som deltar i transnationella forskningskonsortier som har beviljats Sida-finansiering i JPIAMR utlysningarna Diagnostics and Surveillance of Antimicrobial Resistance: Development of tools, technologies and methods for global use och AquaticPollutants.

M&#xE5;ls&#xE4;ttningen med partnerskapet mellan Sida, APHRC och JPIAMR &#xE4;r att flera l&#xE4;nders resurser, infrastruktur och styrkor sluts samman f&#xF6;r att facilitera innovativa forskningsprojekt f&#xF6;r att bromsa utveckling och spridning av AMR med en s.k. One Health-ansats som integrerar human, djur och milj&#xF6;h&#xE4;lsa; att st&#xF6;dja och &#xF6;ka deltagandet av forskare i l&#xE5;ginkomstl&#xE4;nder i Afrika s&#xF6;der om Sahara och andra l&#xE4;nder i omr&#xE5;det d&#xE4;r Sverige har bilateralt utvecklingssamarbete i den globala kampen mot AMR; och att bygga kapacitet och st&#xF6;dja bildandet av ett n&#xE4;tverk av AMR-forskare p&#xE5; den afrikanska kontinenten.

JPIAMR &#xE4;r en global organisation och samarbetsplattform d&#xE4;r 28 nationer arbetar tillsammans f&#xF6;r att begr&#xE4;nsa utvecklingen och konsekvenserna av AMR med hj&#xE4;lp av en One Health-ansats. Sida har hittills deltagit i tv&#xE5; JPIAMR utlysningar d&#xE4;r beslut om bidrag har fattats:

JPIAMR utlysningen 2019 Diagnostics and Surveillance of Antimicrobial Resistance: Development of tools, technologies and methods for global use d&#xE4;r fem projekt med deltagare fr&#xE5;n sju afrikanska forskningsinstitutioner i  Burkina Faso, Gambia, Kenya, Madagascar, Tanzania, Togo and Uganda har beviljats medel fr&#xE5;n Sida;

Utlysningen 2020 AquaticPollutants, ett gemensamt initiativ av JPIAMR, JPI Oceans och Water JPI, d&#xE4;r tre projekt med deltagare fr&#xE5;n fyra afrikanska forskningsinstitutioner i Mali, Mozambique and Uganda har beviljats.</narrative>
   <narrative xml:lang="EN">The African Populations Health and Research Center (APHRC) has applied to Sida for funding of 22.9 million SEK to provide grant management services plus additional capacity building and networking activities for African grantees funded by research calls of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) during the period 2021-06-01 until 2024-12-31. Of the 22.9 million SEK, 14.6 million SEK will be forwarded to African researchers participating in transnational research consortia that have been granted Sida funding in the JPIAMR research calls Diagnostics and Surveillance of Antimicrobial Resistance: Development of tools, technologies and methods for global use and AquaticPollutants.

The objectives of the proposed Sida partnership with APHRC and JPIAMR are to combine resources, infrastructures, and strengths of multiple countries in order to facilitate innovative research projects to curb AMR with an One Health approach integrating human, animal and environmental health; to support and increase the participation of researchers in low-income countries in sub-Saharan Africa and other sub-Saharan countries where Sweden has bilateral development cooperation in the global fight against AMR; and to build capacity and support the formation of a network of AMR researchers on the African continent.

JPIAMR is a global collaborative organization and platform, engaging 28 nations to curb AMR with a One Health approach. Sida has up to now participated in two JPIAMR research calls where funding decisions have been made:

JPIAMR call 2019 Diagnostics and Surveillance of Antimicrobial Resistance: Development of tools, technologies and methods for global use where five projects with participants from seven African institutions in Burkina Faso, Gambia, Kenya, Madagascar, Tanzania, Togo and Uganda have been selected for Sida funding;

Call 2020 AquaticPollutants, a common initiative of JPIAMR, JPI Oceans and Water JPI, where three projects with participants from four African institutions in Mali, Mozambique and Uganda have been selected for Sida funding.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">The overall objective of the program is to provide fund management support to implementing partners with the aim to:
1. Increase timeliness, efficiency and effectiveness in the implementation of the projects at partner institutions;
2. Strengthen the research and grant management capacities of AMR researchers and implementing partners to support:
a) adoption of best practices in AMR research and grant management;b) enhancement of quality and relevance of AMR research projects from implementing partners;c) award winning grant proposal development;&#xA0;d) networking and collaborations on projects among the cohort of AMR researchers and implementing partners;e) engagement of AMR researchers with the community and policy actors.
The expected outcomes of the program are:
1. Strengthened research, governance and management systems within institutions supporting AMR research and response;
2. A strong network of AMR researchers collaboratively and effectively engaging with policy actors in projects aimed at prevention and treatment of bacterial, parasitic, viral and fungal infections and diseases.Ultimately, APHRC envisages greater effective collaboration of AMR actors in the prevention and treatment of bacterial, parasitic, viral and fungal infections and diseases.</narrative>
  </description>
  <participating-org ref="51000" role="2">
   <narrative xml:lang="EN">APHRC/African Population and Health Research Center</narrative>
  </participating-org>
  <participating-org ref="51000" role="4" type="80">
   <narrative xml:lang="EN">APHRC/African Population and Health Research Center</narrative>
  </participating-org>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-6" role="3" type="10">
   <narrative xml:lang="EN">Swedish International Development Cooperation Agency</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2021-06-01" type="1"></activity-date>
  <activity-date iso-date="2021-06-01" type="2"></activity-date>
  <activity-date iso-date="2026-06-30" type="3"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">Swedish International Development Cooperation Agency</narrative>
   </organisation>
   <telephone>+46 8 698 50 00</telephone>
   <email>sida@sida.se</email>
   <website>www.sida.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Valhallav&#xE4;gen 199, 105 25 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-region code="298" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Africa, regional</narrative>
  </recipient-region>
  <sector code="122" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Basic Health</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Infectious disease control</narrative>
  </sector>
  <tag code="3.3" vocabulary="3">
   <narrative xml:lang="EN">3.3 - By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases.</narrative>
   <narrative xml:lang="SV">3.3 - Senast 2030 utrota epidemierna av aids, tuberkulos, malaria och f&#xF6;rsummade tropiska sjukdomar samt bek&#xE4;mpa hepatit, vattenburna sjukdomar och andra smittsamma sjukdomar.</narrative>
  </tag>
  <tag code="3.9" vocabulary="3">
   <narrative xml:lang="EN">3.9 - By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination.</narrative>
   <narrative xml:lang="SV">3.9 - Till 2030 v&#xE4;sentligt minska antalet d&#xF6;ds- och sjukdomsfall till f&#xF6;ljd av skadliga kemikalier samt f&#xF6;roreningar och kontaminering av luft, vatten och mark.</narrative>
  </tag>
  <tag code="3.B" vocabulary="3">
   <narrative xml:lang="SV">3.b - St&#xF6;dja forskning om och utveckling av vaccin och l&#xE4;kemedel mot de smittsamma och icke-smittsamma sjukdomar som i f&#xF6;rsta hand drabbar utvecklingsl&#xE4;nder. S&#xF6;rja f&#xF6;r tillg&#xE5;ng till ekonomiskt &#xF6;verkomliga grundl&#xE4;ggande l&#xE4;kemedel och vaccin, i enlighet med Doha-deklarationen om TRIPS-avtalet och folkh&#xE4;lsa, i vilken det bekr&#xE4;ftas att utvecklingsl&#xE4;nderna har r&#xE4;tt att fullt ut utnyttja den flexibilitet som avtalet om handelsrelaterade aspekter av immaterialr&#xE4;tter erbjuder f&#xF6;r att skydda folkh&#xE4;lsan och, framf&#xF6;r</narrative>
   <narrative xml:lang="EN">3.b - Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public healt</narrative>
  </tag>
  <tag code="3.D" vocabulary="3">
   <narrative xml:lang="EN">3.d - Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks.</narrative>
   <narrative xml:lang="SV">3.d - St&#xE4;rka alla l&#xE4;nders, i synnerhet utvecklingsl&#xE4;ndernas, kapacitet n&#xE4;r det g&#xE4;ller tidig varning, riskreducering och hantering av nationella och globala h&#xE4;lsorisker.</narrative>
  </tag>
  <tag code="6.3" vocabulary="3">
   <narrative xml:lang="EN">6.3 - By 2030, improve water quality by reducing pollution, eliminating dumping and minimizing release of hazardous chemicals and materials, halving the proportion of untreated wastewater and substantially increasing recycling and safe reuse globally.</narrative>
   <narrative xml:lang="SV">6.3 - Till 2030 f&#xF6;rb&#xE4;ttra vattenkvaliteten genom att minska f&#xF6;roreningar, stoppa dumpning och minimera utsl&#xE4;pp av farliga kemikalier och material, halvera andelen obehandlat avloppsvatten och v&#xE4;sentligt &#xF6;ka &#xE5;tervinningen och en s&#xE4;ker &#xE5;teranv&#xE4;ndning globalt.</narrative>
  </tag>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disability</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget>
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-28"></period-end>
   <value currency="USD" value-date="2021-01-01">524665.0887849922</value>
  </budget>
  <budget>
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-28"></period-end>
   <value currency="USD" value-date="2022-01-01">2178409.4486352876</value>
  </budget>
  <budget>
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-12-28"></period-end>
   <value currency="USD" value-date="2023-01-01">1912695.7292261773</value>
  </budget>
  <budget>
   <period-start iso-date="2024-01-01"></period-start>
   <period-end iso-date="2024-12-28"></period-end>
   <value currency="USD" value-date="2024-01-01">1133101.7034126548</value>
  </budget>
  <budget>
   <period-start iso-date="2025-01-01"></period-start>
   <period-end iso-date="2025-12-28"></period-end>
   <value currency="USD" value-date="2025-01-01">200072.2871900104</value>
  </budget>
  <planned-disbursement>
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-28"></period-end>
   <value currency="USD" value-date="2021-01-01">524665.0887849922</value>
  </planned-disbursement>
  <planned-disbursement>
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-28"></period-end>
   <value currency="USD" value-date="2022-01-01">2178409.4486352876</value>
  </planned-disbursement>
  <planned-disbursement>
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-12-28"></period-end>
   <value currency="USD" value-date="2023-01-01">1912695.7292261773</value>
  </planned-disbursement>
  <planned-disbursement>
   <period-start iso-date="2024-01-01"></period-start>
   <period-end iso-date="2024-12-28"></period-end>
   <value currency="USD" value-date="2024-01-01">1133101.7034126548</value>
  </planned-disbursement>
  <planned-disbursement>
   <period-start iso-date="2025-01-01"></period-start>
   <period-end iso-date="2025-12-28"></period-end>
   <value currency="USD" value-date="2025-01-01">200072.2871900104</value>
  </planned-disbursement>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-06-01"></transaction-date>
   <value currency="USD" value-date="2021-06-01">5948944.257249</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-28"></transaction-date>
   <value currency="USD" value-date="2021-08-28">524665.0887849922</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-01-28"></transaction-date>
   <value currency="USD" value-date="2022-01-28">1010194.942228544</value>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://documents.iati.openaid.se/document/forsk/15166_043769-21Avtalsandring_Amendment1totheAgreementonJointProgrammingInitiativeonAn3045408_1_1.pdf">
   <title>
    <narrative xml:lang="EN">Agreement Amendment 1 JPIAMR 2021</narrative>
   </title>
   <category code="A09"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://documents.iati.openaid.se/document/forsk/15166_027917-21Avtal-GrantAgreementbetweenSidaandAPHRCregardingJointProgrammingIniti2975640_1_1.pdf">
   <title>
    <narrative xml:lang="EN">Grant Agreement between Sida and APHRC regarding JPIAMR</narrative>
   </title>
   <category code="A09"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://documents.iati.openaid.se/document/forsk/15166_041053-21DecisiononAmendmentofContribution(15166)2111193033472_1_1.pdf">
   <title>
    <narrative xml:lang="SV">Beslut om avtals&#xE4;ndring 1 JPIAMR 2021</narrative>
   </title>
   <category code="A11"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://documents.iati.openaid.se/document/forsk/15166_024302-21Beslutominsats,JointProgrammingInitiativeonAntimicrobialResistance(JPIA2958118_1_1.pdf">
   <title>
    <narrative xml:lang="SV">Beslut om insats JPIAMR</narrative>
   </title>
   <category code="A11"></category>
  </document-link>
  <sida:contribution contributionid="15166" xmlns:sida="http://sida.se/ns/contribution#"></sida:contribution>
  <sida:strategies xmlns:sida="http://sida.se/ns/strategies#">
   <sida:strategy code="1140102" currency="SEK" strategy-amount="0" strategy-end-date="2022-12-31" strategy-start-date="2015-01-01">
    <sida:title>Research cooperation 2015-2022</sida:title>
    <sida:titleSV>Forskningssamarbete 2015-2022</sida:titleSV>
   </sida:strategy>
  </sida:strategies>
 </iati-activity>
</iati-activities>
